持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/09/12 | 3,235 | 3,255 | 3,210 | 3,210 | -15 | -0.5% | 31,700 |
| 2025/09/11 | 3,240 | 3,255 | 3,205 | 3,225 | -15 | -0.5% | 13,800 |
| 2025/09/10 | 3,260 | 3,280 | 3,240 | 3,240 | -20 | -0.6% | 19,900 |
| 2025/09/09 | 3,290 | 3,310 | 3,250 | 3,260 | -30 | -0.9% | 20,900 |
| 2025/09/08 | 3,265 | 3,290 | 3,250 | 3,290 | +55 | +1.7% | 19,800 |
| 2025/09/05 | 3,200 | 3,250 | 3,185 | 3,235 | +20 | +0.6% | 20,600 |
| 2025/09/04 | 3,200 | 3,250 | 3,190 | 3,215 | +25 | +0.8% | 24,800 |
| 2025/09/03 | 3,185 | 3,205 | 3,170 | 3,190 | +20 | +0.6% | 25,200 |
| 2025/09/02 | 3,170 | 3,205 | 3,170 | 3,170 | +10 | +0.3% | 16,500 |
| 2025/09/01 | 3,125 | 3,185 | 3,120 | 3,160 | +50 | +1.6% | 16,300 |
| 2025/08/29 | 3,125 | 3,150 | 3,110 | 3,110 | -15 | -0.5% | 19,700 |
| 2025/08/28 | 3,160 | 3,160 | 3,125 | 3,125 | -20 | -0.6% | 18,800 |
| 2025/08/27 | 3,115 | 3,160 | 3,100 | 3,145 | +30 | +1% | 24,900 |
| 2025/08/26 | 3,220 | 3,230 | 3,115 | 3,115 | -70 | -2.2% | 67,400 |
| 2025/08/25 | 3,220 | 3,220 | 3,180 | 3,185 | -35 | -1.1% | 18,700 |
| 2025/08/22 | 3,210 | 3,230 | 3,195 | 3,220 | +50 | +1.6% | 18,600 |
| 2025/08/21 | 3,180 | 3,200 | 3,170 | 3,170 | -15 | -0.5% | 17,300 |
| 2025/08/20 | 3,170 | 3,205 | 3,165 | 3,185 | +15 | +0.5% | 14,300 |
| 2025/08/19 | 3,145 | 3,185 | 3,145 | 3,170 | +15 | +0.5% | 17,000 |
| 2025/08/18 | 3,170 | 3,185 | 3,140 | 3,155 | +20 | +0.6% | 23,600 |
| 2025/08/15 | 3,185 | 3,185 | 3,115 | 3,135 | -30 | -0.9% | 22,600 |
| 2025/08/14 | 3,185 | 3,195 | 3,160 | 3,165 | -45 | -1.4% | 17,300 |
| 2025/08/13 | 3,235 | 3,250 | 3,190 | 3,210 | -25 | -0.8% | 36,800 |
| 2025/08/12 | 3,200 | 3,245 | 3,190 | 3,235 | +10 | +0.3% | 25,700 |
| 2025/08/08 | 3,195 | 3,255 | 3,195 | 3,225 | -5 | -0.2% | 23,800 |
| 2025/08/07 | 3,300 | 3,300 | 3,225 | 3,230 | -70 | -2.1% | 23,900 |
| 2025/08/06 | 3,245 | 3,305 | 3,230 | 3,300 | +60 | +1.9% | 24,000 |
| 2025/08/05 | 3,180 | 3,260 | 3,180 | 3,240 | +75 | +2.4% | 29,600 |
| 2025/08/04 | 3,160 | 3,235 | 3,140 | 3,165 | -65 | -2% | 37,800 |
| 2025/08/01 | 3,115 | 3,245 | 3,100 | 3,230 | +135 | +4.4% | 72,000 |
| 2025/07/31 | 3,085 | 3,115 | 3,075 | 3,095 | +30 | +1% | 25,700 |
| 2025/07/30 | 3,080 | 3,085 | 3,055 | 3,065 | -20 | -0.6% | 18,300 |
| 2025/07/29 | 3,055 | 3,090 | 3,050 | 3,085 | +30 | +1% | 21,800 |
| 2025/07/28 | 3,075 | 3,085 | 3,050 | 3,055 | ±0 | ±0% | 23,000 |
| 2025/07/25 | 3,045 | 3,085 | 3,025 | 3,055 | +20 | +0.7% | 23,300 |
| 2025/07/24 | 3,030 | 3,050 | 3,025 | 3,035 | +10 | +0.3% | 23,600 |
| 2025/07/23 | 2,980 | 3,035 | 2,980 | 3,025 | +55 | +1.9% | 30,600 |
| 2025/07/22 | 3,030 | 3,030 | 2,969 | 2,970 | -20 | -0.7% | 25,900 |
| 2025/07/18 | 3,025 | 3,025 | 2,977 | 2,990 | -20 | -0.7% | 16,400 |
| 2025/07/17 | 2,930 | 3,010 | 2,928 | 3,010 | +65 | +2.2% | 23,200 |
| 2025/07/16 | 2,934 | 2,970 | 2,932 | 2,945 | -14 | -0.5% | 26,100 |
| 2025/07/15 | 2,957 | 2,991 | 2,947 | 2,959 | +13 | +0.4% | 14,100 |
| 2025/07/14 | 2,910 | 2,963 | 2,910 | 2,946 | +38 | +1.3% | 21,100 |
| 2025/07/11 | 2,906 | 2,926 | 2,902 | 2,908 | +27 | +0.9% | 15,200 |
| 2025/07/10 | 2,919 | 2,919 | 2,868 | 2,881 | -5 | -0.2% | 44,000 |
| 2025/07/09 | 2,881 | 2,914 | 2,878 | 2,886 | +26 | +0.9% | 20,600 |
| 2025/07/08 | 2,896 | 2,897 | 2,859 | 2,860 | -30 | -1% | 29,800 |
| 2025/07/07 | 2,907 | 2,916 | 2,890 | 2,890 | -11 | -0.4% | 22,700 |
| 2025/07/04 | 2,901 | 2,907 | 2,882 | 2,901 | +1 | ±0% | 19,900 |
| 2025/07/03 | 2,930 | 2,948 | 2,900 | 2,900 | -29 | -1% | 20,500 |
1～
50
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 324,000円 | +5.1% | -7.0% | 2.47% | 21.27倍 | 0.88倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 東和薬品 | 298,400円 | +7.9% | -3.3% | 2.68% | 8.30倍 | 0.85倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ジーエヌアイ | 251,800円 | +21.7% | +999.9% | 0.00% | 11.60倍 | 3.96倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 211,600円 | +3.1% | -6.5% | 2.27% | 9.81倍 | 1.04倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 157,000円 | -2.4% | -52.3% | 3.63% | 18.79倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
